Teneligliptin 20mg + Metformin 500mg
/ Pack :
1 X 10s
/ Type :
Since DPP-4 inhibitors and metformin improve glycemic control via different albeit potentially complementary mechanisms. Combination therapy with these two agents should provide effective and potentially additive glycemic control. Studies using combination therapy of DPP-4 inhibitors and metformin (as one pill) showed favorable results in glycemic control because of favorable pharmacokinetic characteristics and complementary pharmacodynamic effects, which include enhanced incretin effect, suppressed hepatic glucose production, and improved peripheral insulin sensitivity. Moreover, in general, the combination of this drug into a single tablet improves patients’ compliance and often results in a lower cost of treatment. Indeed several fixed-dose combinations have been developed and/or commercialized - Diabetes Metab Syndr Obes. 2013; 6: 187–195.
View more products with following salts
Metformin 500mg Teneligliptin 20mg